Management ChangeJun 12, 2026, 04:12 PM
Sagimet Biosciences: Tim Walbert Resigns; Four Directors Elected at AGM
AI Summary
Sagimet Biosciences announced that Tim Walbert resigned from its Board of Directors, effective June 12, 2026, citing other commitments and no disagreements with the company. Concurrently, at its 2026 Annual Meeting of Stockholders, Jennifer Jarrett, Anne Phillips, David Happel, and George Kemble were elected as Class III directors to serve until the 2029 Annual Meeting. Additionally, stockholders ratified the appointment of KPMG LLP as the company's independent registered public accounting firm for the 2026 fiscal year.
Key Highlights
- Tim Walbert resigned from Sagimet Biosciences' Board of Directors, effective June 12, 2026.
- His resignation was due to other commitments and not any disagreement with the company.
- Jennifer Jarrett, Anne Phillips, David Happel, and George Kemble were elected as Class III directors.
- The newly elected directors will serve until the 2029 Annual Meeting of Stockholders.
- Stockholders ratified KPMG LLP as the independent registered public accounting firm for the 2026 fiscal year.
- KPMG LLP ratification received 19,091,619 votes For, 13,960 Against, and 35,224 Abstentions.
Price Impact
More from SGMT